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Abstract
A detailed understanding of the fate of xenobiotics introduced into the environment and the mechanisms involved in their 
biotransformation, biodegradation, and biosorption is essential to improve the efficiency of remediation techniques. Mycore-
mediation is a form of bioremediation technique that has become increasingly popular in recent years as fungi are known to 
produce various effective extracellular enzymes that have the potential to neutralize a wide variety of xenobiotics released 
into the environment. Hence, mycoremediation appears to be a promising technique for the removal of a wide array of toxins 
and pharmaceutical residues from a damaged environment and wastewater. This study primarily aimed to investigate whether 
white-rot fungus (Lentinula edodes) can be utilized for the bioremediation of common antifungal agent terbinafine, which 
is mainly available in the market as powder or cream. The cultures of L. edodes were cultivated in the medium containing 
terbinafine powder or terbinafine 1% cream, each at a final concentration of 0.1 mg mL−1. The addition of terbinafine in 
powder form have a negative effect on biomass growth (p < 0.05). The total amount of terbinafine in the dry weight of myce-
lium after culture was estimated to be 7.63 ± 0.45 mg and 12.52 ± 2.46 mg for powder and cream samples, respectively. In 
addition, there were no traces of terbinafine in any of the samples of medium used for culturing L. edodes after the experi-
mental duration period. The biodegradation products of terbinafine were identified for the first time using UPLC/MS/MS. 
The biodegradation of terbinafine resulted in the loss of 1-naphthylmethanol, which occurred via oxidative deamination, 
N-demethylation, or tert-butyl group hydroxylation. The results of the study demonstrate that L. edodes mycelium can be 
effectively used for the remediation of terbinafine.
Keywords Terbinafine · Biodegradation · Lentinula edodes · Edible mushrooms
Introduction
Environmental pollution with drugs, pesticides, and per-
sonal care products is one of the most challenging issues 
that the world is facing today. Pharmaceutical compounds 
play an indispensable role in the treatment and prevention 
of diseases. Active pharmaceutical ingredients (APIs) can 
enter the environment as a result of various manufacturing 
processes involved in the production of medicinal products, 
following medical diagnosis and therapeutic use of pharma-
ceuticals for the prevention of diseases, or due to disposal 
of unused medications. According to Executive Agency for 
Health and Consumers, the annual worldwide consump-
tion of pharmaceutical compounds is estimated to be about 
100,000 tonnes (Mudgal et al. 2013). APIs and their metabo-
lites are identified in sewage, surface water, soils, sludge, 
and air. Their widespread occurrence and potential adverse 
effects on ecosystems and human health, mainly associated 
with long-term exposure to low concentrations of pharma-
ceuticals, are a subject of public concern (Sousa et al. 2012; 
Patel et al. 2019). After being released into the environment, 
active metabolites might further undergo degradation to pro-
duce toxic end products, which involves complex processes 
that significantly depend on various factors (Boxall, 2004). 
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The investigation concerning the potential risk of drugs 
present in the environment to the aquatic ecosystems is par-
ticularly important (Hilton et al. 2003). Therefore, a better 
understanding of the fate of medicines in the environment 
is crucial in attempting to achieve effective drug removal 
from the surroundings. In response to the growing demand 
for environmental remediation techniques, numerous studies 
on water and soil remediation processes, including in situ 
and ex situ methods, have been carried out. Ex situ meth-
ods involve isolation, transportation, and disposal of pol-
lutants at a distant and safe place, but this procedure has 
been proven to be very expensive. In general, technologies 
based on physicochemical characteristics of pollutants, such 
as photocatalytic advanced oxidation processes, membrane-
based techniques (membrane filtration and reverse osmo-
sis) and chemical and physical adsorption mechanisms, are 
considered to be highly efficient and cost-effective methods 
(Kryczyk et al. 2016; Bartolomeu et al. 2018; Warsinger 
et al. 2018). The recent studies and development in this field 
are mainly based on the use of nanotechnology, as this novel 
approach is known to yield better results than the conven-
tional methods. Another possible approach is based on the 
use of eco-friendly biological processes such as in situ bio-
degradation. Biological decomposition (bioremediation) is 
an effective strategy for the removal or transformation of 
xenobiotics into less toxic forms. Studies conducted world-
wide have reported that antifungal drugs (pharmaceutical 
fungicides) pose a potential threat to the ecosystem. These 
drugs, particularly those registered for both human and vet-
erinary use, are commonly used as oral or topical agents. 
This class of drugs could be found in cosmetic products 
and can be obtained as over-the-counter drugs. In addi-
tion, antifungal agents are also widely used in agriculture. 
Reports of the latest studies establish antifungal drugs as 
the emerging environmental contaminants (Chen and Ying 
2015). The persistence of antifungal drugs in soil and water 
is highly variable, and it has been observed that some azole 
antifungals have increased stability and could remain active 
in some ecological conditions for months (Hof 2001). In 
Sweden, these agents have been detected in sludge, and the 
concentrations of clotrimazole, ketoconazole, and econazole 
are reported to be in the range of 200–1000 µg kg−1 dry 
weight (Lindberg et al. 2010). The occurrence of antifun-
gal agents in the environment has been confirmed in studies 
conducted locally in many countries (Lindberg et al. 2010; 
Chen and Ying, 2015; Balakrishna et al. 2017). Terbinafine, 
an antifungal agent, was detected in the water samples col-
lected from the wells of India at a concentration of more than 
1 μg L−1 (Fick et al. 2009). Furthermore, this compound was 
also isolated there from lakes and rivers (Fick et al. 2009). 
In our previous work, we focused on the mycoremedia-
tion of antifungal drugs from the azole group: clotrimazole 
and bifonazole (Kryczyk-Poprawa et al. 2019). This study 
primarily aimed to investigate whether white-rot fungus can 
be effectively utilized for the bioremediation of common 
antifungal agent terbinafine (in powder and cream forms). 
Terbinafine hydrochloride, a synthetic allylamine derivative, 
is widely used for the treatment for fungal infections owing 
to the fact that it exhibits broad-spectrum antifungal activ-
ity and its price is relatively low when compared to other 
antifungals. Hence, this drug was selected for investigation 
purpose in the present study. Terbinafine acts by reversible 
inhibition of squalene epoxidase, an enzyme responsible 
for ergosterol biosynthesis. This biochemical mechanism is 
responsible for the fungistatic and fungicidal activity of the 
drug on fungal mycelia. According to the current medical 
guidelines, terbinafine is recommended as the first-line treat-
ment for dermatophyte onychomycosis, mainly due to its 
high efficacy and tolerability properties (Ameen et al. 2014). 
In 2001, about 1.5 million prescriptions for drugs containing 
terbinafine were issued in the US alone (Davis et al. 2019). 
Mushroom cultures could also be utilized to remove xenobi-
otics from the environment (Kryczyk et al. 2017; Dąbrowska 
et al. 2018). Lentinula edodes was selected for the current 
study because of its unique nutritional and healing proper-
ties. The Japanese common name of L. edodes is “shitake.” 
The fruiting bodies of L. edodes contain a number of com-
pounds that contribute to its pharmacological effects, mainly 
immunomodulatory and anticancer properties. The fruiting 
bodies of this species are rich in bioactive polysaccharides 
such as β-d-glucans (lentinan), monosaccharides, vitamins, 
and eritadenine (2(R),3(R)-dihydroxy-4-(9-adenyl) butyric 
acid). These mushrooms also produce many enzymes, such 
as peroxidase, cellulase, pectinase, xylanase, ligninase, and 
oxidase. Since L. edodes produces oxidative and hydrolytic 
extracellular enzymes, it can participate in xenobiotic deg-
radation process (Leatham 1985). Additionally, this species 
was effectively used for the remediation of azole antifungal 
drugs (Kryczyk-Poprawa et al. 2019). For the above-men-
tioned reasons, the mycoremediation potential of L. edodes 
mycelia against terbinafine was investigated in in vitro 
cultures. The medium used for culturing L. edodes was 
enriched with terbinafine powder or terbinafine 1% cream 
with the final concentration of the investigated drug being 
0.1 mg mL−1. The biodegradation products of terbinafine 
were analyzed by UPLC/MS/MS method.
Materials and methods
Reagents
Terbinafine hydrochloride (pharmaceutical secondary stand-
ard) was obtained from Sigma-Aldrich Corp. (St. Louis, 
MO, USA). HPLC-grade methanol, acetonitrile, formic 
acid (98%), chloramphenicol, and dichloromethane were 
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obtained from Merck (Darmstadt, Germany). Chemicals 
like glucose, maltose extract, casein hydrolysate, l-aspar-
agine, adenine, and yeast extract were purchased from 
Sigma-Aldrich (St. Louis, MO, USA).  NH4Cl,  KH2PO4, 
 MgSO4⋅7H2O,  CaCl2⋅6H2O,  FeCl3,  MnSO4⋅H2O, and 
 ZnSO4⋅7H2O were purchased from PPH Golpharm (Kraków, 
Poland). Water (quadruple-distilled) with a conductivity of 
less than 1 μS cm−1 was obtained using an S2-97A2 distil-
lation apparatus (ChemLand, Stargard Szczeciński, Poland). 
Terbinafine cream (Terbinafina Ziaja, Ziaja, Poland) was 
obtained from a local pharmacy store.
Materials for analysis
For the study, commercially available fruiting bodies of L. 
edodes (Berk.) (Pegler (mushroom) were bought at a super-
market in Poland (2016). The taxonomic identification of the 
fungus was performed using MycoKey 4.1 software (https 
://www.mycok ey.com) by an expert named Muszyńska. The 
representative samples of the material to be used for further 
studies were stored at the Department of Pharmaceutical 
Botany, Jagiellonian University Medical College, Kraków, 
Poland. Fragments of the hymenial part of fruiting bodies 
were selected to prepare the mycelial culture of L. edodes. 
First, the fragments of the fruiting bodies were mixed with 
sterile redistilled water and transferred to the BD Sabouraud 
agar supplemented with chloramphenicol (under laminar 
airflow). Then, the cultures were incubated in a thermo-
stat (ST500/B/40 Pol-Eko-Apparatus) at 23 °C ± 2 °C for 
2 weeks. Microscopic analysis of the obtained mycelium 
of L. edodes was performed by Muszyńska. It showed the 
homogeneous nature of hyphae, which was free from con-
tamination with other strains of fungi or bacteria. The myce-
lia obtained from the solid medium were used to prepare 
initial cultures that were grown on liquid Oddoux medium 
(Oddoux 1957). The cultures were shaken on a rotary shaker 
(ALTEL, Poland) at a rate of 140 rpm and incubated at a 
temperature of 23 °C ± 2 °C under 12-h light (900 lx)/12-h 
dark cycle. The cultures of L. edodes were maintained for 
two weeks and later subcultured (Fig. 1).
The obtained L. edodes mycelium was analyzed by PCR 
method. GenBank Accession Number SUB6791903 Seq 1 
MN907099 was assigned to the nucleotide sequence deter-
mined in this study.
Experimental mycelial cultures of L. edodes
For mycoremediation studies, 25 mg of terbinafine powder 
or 2.5 g of terbinafine 1% cream was added into 250 mL 
of sterile liquid medium inoculated with a mycelial culture 
of L. edodes. Terbinafine 1% cream (Ziaja) containing iso-
propyl myristate, cetyl alcohol, stearyl alcohol, sorbitan 
stearate (Type 50), cetyl palmitate (15), polysorbate 60, 
benzyl alcohol, sodium hydroxide, and purified water was 
used. Moreover, control samples were prepared without the 
addition of terbinafine. After inoculation, the cultures were 
incubated for 14 days. Then, the biomass of L. edodes was 
separated from the medium, rinsed with redistilled water, 
and then freeze-dried using a lyophilizer (FreeZone 4.5, 
Labconco).
RP‑HPLC analysis
Five grams of the lyophilized mushroom culture (mycelium 
obtained from in vitro cultures) was ground in a mortar and 
then extracted with a mixture of methanol and dichlorometh-
ane (75:25, v/v) in an ultrasonic bath at 49 kHz for 30 min 
(Sonic-2, Polsonic). The obtained extracts (300 mL) were 
evaporated to dryness using a rotary vacuum evaporator at 
22 °C ± 2 °C, and then the dried extracts were dissolved 
in methanol and filtered through a 0.2-μm filter. The con-
centration of terbinafine was determined using RP-HPLC 
according to the procedure developed by Tagliari (2010). 
Briefly, the separation was carried out on Hitachi HPLC 
apparatus (Merck, Tokyo, Japan) equipped with an L-7100 
pump, Purospher® RP-C18 (200 mm × 4 mm , 5 μm) column 
(Merck, Tokyo, Japan), using methanol–water (95:5, v/v) 
as a mobile phase, and a flow rate of 1 mL min−1 with UV 
detection at λ = 254 nm. The qualitative analysis of terbi-
nafine was done by comparing the retention times of the 
peaks in the samples with the retention times of standard. 
To confirm the presence of terbinafine in the tested extracts, 
a standard solution was added to the samples. The presence 
of the tested compound in the sample was indicated by an 
increase in the peak height for the appropriate retention 
time. In addition, MS/MS analysis was also performed. The 
quantitative analysis of terbinafine was carried out using 
Fig. 1  L. edodes in vitro cultures enriched with the addition of 2.5 g 
of terbinafine 1% cream or 25 mg terbinafine powder per 250 mL of 
the Oddoux medium (picture taken by Agata Kryczyk-Poprawa)
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the calibration curve method where the concentration of the 
standard drug was in the range from 0.01 to 0.1 mg mL−1.
UPLC/MS/MS analysis
About 200 μL of the sample was evaporated and diluted 
in 300 μL of water with the addition of 1% formic acid. 
The samples were applied to the SPE cartridges (Waters 
Oasis HLB Cartridge, USA) and washed with 1 mL of 
water, followed by the addition of 1 mL of methanol–water 
(50:50, v/v) mixture, and then eluted with 1 mL of metha-
nol. The prepared samples were injected into the UPLC/MS/
MS system for analysis. The UPLC/MS/MS system con-
sisted of a Waters ACQUITY® UPLC® (Waters Corpora-
tion, Milford, MA, USA) coupled to a Waters TQD mass 
spectrometer (electrospray ionization mode ESI-tandem 
quadrupole). Chromatographic separation was carried out 
using Acquity UPLC BEH (bridged ethyl hybrid) C18 col-
umn, 2.1 × 100 mm and 1.7 µm particle size, equipped with 
Acquity UPLC BEH C18 VanGuard pre-column, 2.1 × 5 mm 
and 1.7 µm particle size. The column was maintained at 
40 °C, and eluted under gradient conditions using 95–0% of 
eluent A for 10 min, at a flow rate of 0.3 mL min−1. Eluent A 
was composed of water/formic acid (0.1%, v/v), and eluent B 
was composed of acetonitrile/formic acid (0.1%, v/v). Chro-
matograms were recorded using Waters eλ PDA detector. 
Spectra were evaluated in 200–700 nm range with 1.2-nm 
resolution at a sampling rate of 20 points/s. Mass spectrom-
etry detection settings of Waters TQD mass spectrometer 
were as follows: source temperature 150 °C, desolvation 
temperature 350 °C, desolvation gas flow rate 600 L h−1, 
cone gas flow rate 100 L h−1, capillary potential 3.00 kV, and 
cone potential 6 V. Nitrogen gas was used as both nebulizing 
and drying agent. The data were recorded in the scan mode 
ranging from 50 to 1000 m/z in time intervals of 0.5 s; eight 
scans were summed up to obtain the final spectrum. The data 
acquisition software used was MassLynx V 4.1 (Waters).
Statistical analysis
Statistical analyses were conducted using Microsoft Excel 
2010 and GraphPad Prism v3.02 (GraphPad Software, San 
Diego, CA, USA). Three replicates were used for each sam-
ple. Results are expressed as means and standard deviation 
(SD). One-way analysis of variance test with Tukey’s post 
hoc test of multiple comparisons or Mann–Whitney’s non-
parametric test was applied. Values were considered sig-
nificantly different at p < 0.05. In silico toxicity risk profile 
of biotransformation products was predicted using OSIRIS 
Property Explorer (access: https ://www.organ ic-chemi stry.
org/prog/peo/).
Results and discussion
Biodegradation is a biochemical process that leads to the 
degradation and recycling of xenobiotics. This process pri-
marily involves bacteria, fungi, and algae, and their activ-
ity leads to the decomposition of the initial substance into 
simpler compounds, which do not usually exhibit toxic 
effects. Due to increasing risks associated with envi-
ronmental pollution, novel methods showing increased 
bioremediation efficiency and new possibilities of its 
application are being explored. It should be emphasized 
that mycoremediation has become an increasingly popular 
method for the removal of pollutants from the environ-
ment, and, therefore, studies to identify new fungal species 
with the potential to degrade xenobiotic compounds to 
evaluate the effectiveness of mushroom-based remediation 
techniques are highly warranted. The knowledge regard-
ing the biodegradation and biotransformation of antifungal 
drugs by the mycelia obtained from in vitro cultures is 
one of the essential elements that prompted us to select 
white-rot fungus, L. edodes, for mycoremediation of the 
xenobiotic in our study.
Terbinafine is metabolized in animals and humans 
(Schatz et  al. 1986). It is absorbed from the gastroin-
testinal tract in more than 70% of the individuals after 
oral administration, following intake of 250 mg of the 
drug, and its maximum plasma concentration is noticed 
within 1.5 h (Elewski et al. 2005). The drug accumulates 
in adipose tissue and keratin-rich tissues (dermis, hair, 
and nails), wherein effective fungicidal concentration is 
observed. It is metabolized in the presence of CYP iso-
enzymes to metabolites that lack antifungal activity. Fif-
teen liver metabolites of terbinafine have been described 
during preclinical and clinical studies (Iverson and Uetre-
cht, 2001). The hepatic metabolism of terbinafine mainly 
takes place through N-demethylation, deamination, and 
oxidation of the alkyl side chain (Vickers et al. 1999). 
The present study was undertaken to compare the biodeg-
radation products of terbinafine, its hepatic metabolites, 
and its photoproducts formed under UVA irradiation. The 
identification of the degradation products of terbinafine in 
the mycelium obtained from in vitro cultures of L. edodes 
was performed on the basis of UPLC/MS/MS analysis. 
The proposed structures of the degradation products of 
terbinafine are shown in Fig. 2. Two biodegradation prod-
ucts of terbinafine (TP-1 and TP-7) have been previously 
described. TP-1 and TP-7 were formed during degradation 
of terbinafine in the presence of UVA irradiation (Kryc-
zyk-Poprawa et al. 2019). The biodegradation of terbin-
afine resulted in the loss of 1-naphthylmethanol, which 
occurred via oxidative deamination, N-demethylation, or 
tert-butyl group hydroxylation. The structures of potential 
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products of terbinafine degradation identified in the myce-
lium obtained from in vitro cultures of L. edodes showed 
the following properties: TP-1 produced a [M + H]+ at m/z 
141.1, TP-7 produced a [M + H]+ at m/z 308, and TP-12—
identified for the first time—produced a [M + H]+ at m/z 
278. TP-12 was formed as a result of N-demethylation 
Fig. 2  MS/MS spectra of biodegradation products of terbinafine: a TP-1 and b TP-12, terbinafine, and TP-7
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of terbinafine to desmethyl terbinafine. This compound 
further forms 6, 6-dimethyl-2-hepten-4-ynal in the liver—
a compound that can initiate idiosyncratic drug-induced 
liver toxicity (Iverson and Uetrecht 2001; Barnette et al. 
2019). After previous application of β-glucuronidase 
hydrolysis in urine and plasma, the metabolite TP-7 
was determined which was also identified in mycelium 
(Zehender et al. 1995).
Many ecotoxicological test systems have been introduced 
to study the effect of xenobiotics on the aquatic organisms 
(Küster and Adler 2014). The toxicity studies of terbinafine 
were carried out in the green algae Pseudokirchneriella sub-
capitata. Terbinafine is listed in the Swedish Environmen-
tal Classification of Pharmaceuticals as the only antifungal 
drug that poses moderate risk to the environment alongside 
other compounds such as chlorhexidine, mycophenolic acid 
and norethisterone (Graae and Pålsson 2018). The harmful 
effects of terbinafine hydrochloride have been described in 
Pharmacopeia, in Safety Data Sheet Sect. 2 (Hazards Identi-
fication), where it is mentioned that terbinafine is very toxic 
for aquatic organisms (British Pharmacopoeia Commission 
2015). There are also data on the genotoxic effects of terbi-
nafine (Chien et al. 2012; Tolomeotti et al. 2015). We next 
aimed to evaluate the toxicity–risk predictions of terbin-
afine and its degradation products using OSIRIS Property 
Explorer. The toxicity risk assessment was done based on 
their ability to induce mutagenicity, tumorigenicity, irrita-
tion, and reproductive effects (Table 1). The in silico experi-
ments revealed that terbinafine and its degradation products 
theoretically displayed high tumorigenic activity, which can 
be attributed to the presence of 1-naphthyl fragment. TP-1, 
a product of oxidative deamination, led to the formation of 
1-naphthylmethanol which demonstrated medium mutagenic 
activity; hence, further studies aiming to evaluate its safety 
profile are required.
Figure 3 shows a comparison of dry biomass obtained 
from in vitro cultures of L. edodes enriched with terbin-
afine (2.5 g of terbinafine 1% cream or 25 mg of terbinafine 
powder) and control (without the addition of terbinafine). 
The dry weight of mycelium showed statistically significant 
differences between the control and the fungal sample sup-
plemented with terbinafine powder (p < 0.05). These dif-
ferences may result from terbinafine concentration in the 
medium. The addition of terbinafine in the form of powder, 
which shows poor solubility in the water, probably allows for 
immediate availability of the drug for the remediation pro-
cess, which could have a negative effect on biomass growth. 
In the case of cream, the form of the drug itself slows down 
the rate of release of terbinafine into the medium and, thus, 
limits its availability for the remediation process.
The next stage of the study was to compare of the amount 
of the tested compound present per 1 g of dry matter of the 
mycelium in different samples after the experimental dura-
tion period. The calculation took into account the mass of 
dry mycelium obtained after 4 weeks of cultivation. Figure 4 
presents terbinafine concentrations in mycelium obtained 
from in vitro cultures of L. edodes on Oddoux medium 
enriched with 25 mg of terbinafine or 2.5 g of terbinafine 
1% cream per 250 mL of the medium, respectively. There 
were no statistically significant (p < 0.05) differences in the 
concentration of terbinafine in the mycelium cultured in the 
medium containing different forms of the drug. The content 
of terbinafine in the medium was below the limit of quanti-
fication in all the analyzed samples, which indicates that the 
drug was successfully degraded by the fungus. Therefore, 
mycoremediation can serve as an alternative approach to 
traditional remediation techniques.
Table 1  Toxicity risks 
of terbinafine and its 
biodegradation products 
determined in L. edodes 
mycelium obtained from in vitro 
cultures in which media were 
enriched with terbinafine and 
predicted by OSIRIS Property 
Explorer
Compound Mutagenic Tumorigenic Irritant Repro-
ductive 
effects
Terbinafine – High-risk fragment (1-naphthyl) – –
TP-1 Medium-risk fragment 
(1-naphthylmethanol)
High-risk fragment (1-naphthyl) – –
TP-7 – High-risk fragment (1-naphthyl) – –
TP-12 – High-risk fragment (1-naphthyl) – –
Fig. 3  Comparison of dry matter of Lentinula edodes mycelium 
obtained from in  vitro cultures enriched with the addition of 2.5  g 
of terbinafine 1% cream or 25 mg of terbinafine powder per 250 mL 
of the medium. Statistical analysis: one-way analysis of variance 
(ANOVA), followed by Tukey’s test. Significant difference compared 
to the control group (without terbinafine addition): * p < 0.05, n = 3
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The total content of the investigated drug in L. edodes 
mycelium was calculated on the basis of the terbinafine 
content determined in 1 g of dry matter obtained from L. 
edodes in vitro cultures and the dry weight of the exam-
ined mycelium. The total terbinafine content in L. edodes 
mycelium, obtained from in vitro cultures, in which media 
were enriched with terbinafine in powder or cream form at 
a concentration of 0.1 mg mL−1 was 7.63 ± 0.45 mg and 
12.52 ± 2.46 mg, respectively. The use of two different forms 
of the drug allowed to demonstrate the impact of drug form 
on the process of remediation by L. edodes. A higher amount 
of terbinafine was determined in the dry matter obtained 
from in vitro cultures of L. edodes supplemented with 1% 
cream. In the case of powder, the amount of terbinafine 
determined in the mycelium obtained from in vitro cultures 
of L. edodes and its absence in the medium indicate a more 
advanced process of biodegradation.
Conclusion
Many reports have been published concerning the role of 
antifungal agents in causing environmental pollution. The 
present study focuses on the evaluation of the potential of L. 
edodes to accumulate or/and degrade the common antifungal 
drug terbinafine. In vitro culturing of L. edodes in the pres-
ence of the drug, thanks to the application of reproducible 
culture conditions, and examining the amount of the drug in 
the mycelium after culture allowed for the assessment of the 
remediation process of the examined compound. The study 
results demonstrates that L. edodes can be effectively used 
for the bioremediation of terbinafine.
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